Anheuser-Busch InBev SA/NV (NYSE:BUD) used its 2026 Capital Markets Day in St. Louis to outline the next phase of its 10-year strategy, emphasizing organic growth, portfolio expansion, digital platforms and increased capital-allocation flexibility.
Chief Executive Officer Michel Doukeris said the b
ASML commands a near-monopoly on essential chipmaking equipment with a 29% net margin and strong cash flow, while Intel navigates a turnaround with negative earnings and government ties.
KB Home (NYSE:KBH) reported third-quarter fiscal 2026 results that met or exceeded its guidance despite what executives described as a more difficult housing environment marked by rising mortgage rates, affordability pressures, higher resale inventory and cautious consumers.
The homebuilder generat
Fastly (NASDAQ:FSLY) outlined a strategy centered on expanding its unified edge cloud platform, increasing multi-product adoption, broadening its geographic reach and targeting revenue of $1.1 billion to $1.3 billion by 2029 at its Investor Day.
Chief Executive Officer Kip Compton said the company
Explore Twinqo’s first deposit bonus with a 100% match up to $200 and free spins. The Diamond100 promo includes bonus details, deposit requirements, and a
Corporate Procurement Strategies: Streamlining Physical Workspaces to Drive Operational ROIIn an era dominated by digital transformation, physical workspac
Bruno Morand De Oliveira's purchase brings his direct holdings to over 1 million shares, following a 44% one-year gain for the offshore drilling contractor.
Abeona Therapeutics (NASDAQ:ABEO) highlighted the early commercial progress of ZEVASKYN, its autologous gene-modified cellular sheet therapy for recessive dystrophic epidermolysis bullosa (RDEB), during the H.C. Wainwright 28th Annual conference.
Madhav Vasanthavada, Abeona’s senior vice president
